PwC's Next in Health · 2026-02-09 · 24 min
From the JPM Healthcare Conference in San Francisco, Glenn Hunzinger, PwC’s Health Industries Leader, speaks with Jeremy Gelber, Partner at Vitruvian Partners, and Claire Love, Principal in PwC’s Deals Strategy practice to explore where healthcare investment momentum is building for 2026, how technology is reshaping value creation, and what investors are watching as care models, consumer behavior, and capital deployment continue to evolve.
US Medtech Deals Midyear Outlook 2026: Why companies are investing through uncertainty48 / 100US Health Services Deals Midyear Outlook 2026: Why investors are focusing on resilience and value creation72 / 100US Pharma Deals Midyear Outlook 2026: Why Dealmakers Are Leaning Into Growth76 / 100What to Watch in US Health Policy Before the 2026 MidtermsStrategies for accessing funding and managing risk in rural health transformation